ReviewCancers2023
Optimal Use of Novel Immunotherapeutics in B-Cell Precursor ALL.
Federico Lussana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
6 papers cite it
this paperpooled itcites it
ReviewCancers2023
Federico Lussana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.